Latest Earnings Results: Q3 '26
Estimated EPS
$0.09
Reported EPS
$0.14
Surprise
+60.9%
Estimated Rev
$204.31M
Reported Rev
$206.7M
Surprise
+1.17%
• Reported GAAP EPS of $0.14 down -62.16% YoY • Reported revenue of $206.69M down -7.93% YoY • Inspire Medical Systems expects Full Year 2026 revenue of $850M to $860M, adjusted operating margin of 4.5% to 5.5%, diluted EPS of -$0.36 to -$0.1, and adjusted diluted EPS of $1.2 to $1.4.
Bullish Takeaway
Inspire Medical Systems reported sequential growth and U.S. performance ahead of expectations, gross margin increased with increased Inspire V sales mix, and a new Category I CPT code is approved for 2028.
Bearish Takeaway
Inspire Medical Systems' revenue decreased amid coding and reimbursement challenges, operating expenses increased with restructuring and legal costs, and operating cash flow was $46.4M versus $68.5M.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $0.91 | -- | -- | N/A |
Q3 '26 | $0.09 | $0.14 | 60.90% | BEAT |
Q2 '26 | -$0.24 | $0.14 | 159.34% | BEAT |
Q1 '26 | -$0.28 | $0.10 | 136.32% | BEAT |
Q4 '25 | $0.68 | $1.65 | 143.88% | BEAT |